HIGH

Medtronic MiniMed Paradigm Real-Time Insulin Pump Recalled for 29,074 Units Worldwide (2026)

Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.

Quick Facts at a Glance

Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Medtronic MiniMed Paradigm Real-Time insulin pumps are wearable devices used for continuous insulin delivery in diabetes management. They are part of a family of infusion pumps designed to automate insulin dosing.

Why This Is Dangerous

The device can over-deliver insulin when elevated and under-deliver when lowered, due to changes in hydrostatic and hydrodynamic pressures. This can lead to severe hypoglycemia or diabetic ketoacidosis and potentially death.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

The risk is life-threatening for some users. The recall affects patients who rely on these pumps for daily management and may require urgent medical oversight during replacement.

Practical Guidance

How to identify if yours is affected

  1. Verify your pump model against MMT-522 or MMT-722.
  2. Locate the device's UDI/serial numbers and compare with Medtronic recall list.
  3. Check recall notification letter from Medtronic or FDA notice on enforcement page.

Where to find product info

Recall notices are available from Medtronic and FDA enforcement reports. Useful identifiers include model number and device documentation.

What timeline to expect

4-8 weeks for refunds or replacements after initiating the recall process.

If the manufacturer is unresponsive

  • Document all communications with the manufacturer and clinician.
  • File a complaint with the FDA if the company is non-responsive.
  • Consider seeking guidance from a medical professional for interim diabetes management.

How to prevent similar issues

  • Avoid purchasing older Paradigm/600-series pumps; verify recall status before use.
  • Verify device with manufacturer before starting any replacement plan.
  • Ask about safer, modern insulin pump systems with updated safety features.

Documentation advice

Keep recall letter, model numbers, serials, photos of device, and all correspondence with manufacturer and clinicians.

Product Details

Models: MMT-522, MMT-722. Affected series: Paradigm Real-Time, MiniMed 600 series, BLE 700 series. Sold worldwide with US nationwide distribution in multiple states. Recall quantity: 29,074 units. Recall date: 2026-02-13. Manufacturer: Medtronic MiniMed, Inc. Price information: Unknown. Sold since: Unknown. Country of origin: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 29,074 units recalled
  • Models MMT-522 and MMT-722
  • Worldwide distribution including US states listed
  • Recall date 2026-02-13
  • Hazard: unintended insulin delivery due to pump height
  • No injuries or incidents reported

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
9/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
MMT-522
MMT-722
Paradigm Real-Time Insulin Pump
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more